TLR4 and colorectal carcinoma: Corylin improved intestinal homeostasis to further reduce tumor cell-induced inflammation by inhibiting the TLR4/p38/AP-1 pathway, inflammatory factors, and the contact between bacteria and epithelial cells in CRC mice.